Tracking TBI: neuromonitoring for brain injuries
UC expert discusses advances in neurocritical care with Albany, Georgia's WALB
The University of Cincinnati's Brandon Foreman, MD, discussed advances in multimodal neuromonitoring with Albany, Georgia's WALB-TV.
Like traditional monitoring of a patient's heart rate, blood pressure and oxygen levels, multimodal neuromonitoring tracks similar brain health data points for patients with traumatic brain injuries. Measurements like blood flow, pressure, oxygen and glucose levels in the brain give actionable information over time when treating patients with severe brain trauma.
"What’s happening in the patient on day one is often very different compared to what’s happening to that patient on day three," said Foreman, associate professor of neurology and associate director of neurocritical care research in the Department of Neurology and Rehabilitation Medicine in UC’s College of Medicine and a UC Gardner Neuroscience Institute physician. "We’re learning a lot about what those patterns look like, how individual they are and how we can treat them in a more precise way tailored to that patient."
Read more about multimodal neuromonitoring work at UC.
Featured photo at top of Foreman reviewing brain data on a monitor. Photo/Andrew Higley/UC Marketing + Brand.
Related Stories
UC biologist talks about 'pearmageddon'
March 16, 2026
WLWT talks to UC biologist and Department Head Theresa Culley about invasive, nonnative Callery pear trees that are spreading across Ohio forests after they were introduced by landscapers more than 50 years ago.
Local media highlight completion of Blood Cancer Healing Center fourth and fifth floors
March 16, 2026
Local media including WLWT and the Cincinnati Business Courier highlighted the opening of research laboratories and the UC Osher Wellness Suite and Learning Kitchen at the University of Cincinnati Cancer Center’s Blood Cancer Healing Center.
Trial results support weekly buprenorphine treatment of opioid use disorder during pregnancy
March 16, 2026
Supported by the National Institutes of Health (NIH), researchers led by the University of Cincinnati's John Winhusen published clinical trial results in JAMA Internal Medicine that found administering weekly injectable extended-release buprenorphine for treatment of opioid use disorder during pregnancy led to higher rates of abstinence from illicit opioids than buprenorphine given daily under the tongue, one of the standard methods of treatment.